Catheter Precision Inc. (VTAK)
undefined
undefined%
At close: undefined
0.35
-4.14%
After-hours Dec 13, 2024, 08:00 PM EST

Company Description

Catheter Precision, Inc. develops and delivers electrophysiology products to provide patients, hospitals, and physicians with technologies and solutions to improve the lives of patients with cardiac arrhythmias in the United States.

The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures.

It also provides LockeT, a suture retention device; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device.

The company was formerly known as Ra Medical Systems, Inc and changed its name to Catheter Precision, Inc. in August 2023.

Catheter Precision, Inc. is based in Fort Mill, South Carolina.

Catheter Precision Inc.
Catheter Precision Inc. logo
Country United States
IPO Date Sep 27, 2018
Industry Medical - Devices
Sector Healthcare
Employees 14
CEO David A. Jenkins

Contact Details

Address:
1670 Highway 160 West
Fort Mill, South Carolina
United States
Website https://www.catheterprecision.com

Stock Details

Ticker Symbol VTAK
Exchange AMEX
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001716621
CUSIP Number n/a
ISIN Number US74933X3026
Employer ID 38-3661826
SIC Code 3841

Key Executives

Name Position
David A. Jenkins Chief Executive Officer & Executive Chairman
Margrit Thomassen CPA Interim Chief Financial Officer & Secretary
Missiaen Huck Chief Operating Officer
Marie-Claude Jacques Chief Commercial Officer

Latest SEC Filings

Date Type Title
Nov 25, 2024 DEFA14A Filing
Nov 25, 2024 DEF 14A Filing
Nov 21, 2024 S-1 Filing
Nov 15, 2024 PRE 14A Filing
Nov 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Nov 14, 2024 8-K Current Report
Nov 14, 2024 10-Q Quarterly Report
Nov 13, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Nov 08, 2024 3 Filing
Nov 04, 2024 8-K/A [Amend] Current Report